UM Miller School of Medicine: Dr. C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment
May 25, 2024
May 25, 2024
MIAMI, Florida, May 25 -- The University of Miami's Miller School of Medicine issued the following Q&A on May 23, 2024, with C. Ola Landgren, chief of the Myeloma Division and director of the Myeloma Research Institute at Sylvester Comprehensive Cancer Center:
* * *
By: Charlotte Schubert
The treatment landscape for multiple myeloma, the second most common blood cancer, is shifting rapidly.
Over the last decade, options have evolved from do . . .
* * *
By: Charlotte Schubert
The treatment landscape for multiple myeloma, the second most common blood cancer, is shifting rapidly.
Over the last decade, options have evolved from do . . .